Science and Technology Science and Technology
Wed, June 16, 2010

Impact Fusion International Enters $23.1 Billion Pet Accessories Market With Proprietary Nutraceutical Pet Intact(TM)


Published on 2010-06-16 06:00:15 - Market Wire
  Print publication without navigation


MARGATE, FL--(Marketwire - June 16, 2010) - Impact Fusion International (PINKSHEETS: [ IFUS ]) is formally launching the Pet Intact™ Brand in the North American Market. Pet Intact™ is currently being sold through distribution and the ecommerce website [ www.intactnutrition.com ]. Pet Intact™ is a unique proprietary blend that has no equal in reducing ammonia in the digestive system of consumers' furry family members.

"The Product is on shelves and sales are expected to increase as we expand distribution and create Brand recognition," states CEO Marc Walther. "This is a proprietary blend which maintains pet health and can reduce veterinary visits."

The market for pet accessories, services and products is valued at over $23.1 Billion and Impact Fusion International is positioned to allow consumers a cost-effective, easy way to keep their animals in good health safely and naturally. Currently, the company is pursuing the expansion of the product line through distribution in United States and Canada. [ http://www.intactnutrition.com/pet-intact-products.html ]

Canine Intact™: the only supplement available that has the right mix of ionic minerals and a synergistic herbal blend that fills the void left by even the best pet foods.

Feline Intact™: an all natural blend of ingredients, specially formulated to provide the correct balance of nutritional supplements for your cat.

Read More About Intact Nutrition™ Products: [ http://www.intactnutrition.com/intact-nutrition-products.html ]

Read More About Nutri-Mastic™[ http://www.intactnutrition.com/nutri-mastic.html ]

About Impact Fusion International Inc.
Impact Fusion International, Inc. is in the business of marketing products in the "Health and Wellness" sector of all international markets. It is the company's mission to invent, develop and market these proprietary products worldwide for the health and well being of humans and animals.

This release may include projections of future results and "forward-looking statements" as that term is defined in Section 27A of the Securities Act of 1933 as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934 as amended (the "Exchange Act"). All statements that are included in this release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable; it can give no assurances that such expectations will prove to have been correct. Important factors that could cause actual results to differ materially from the expectations disclosed in this release, including, without limitation, in conjunction with those forward-looking statements contained in this release.

Contributing Sources